191 related articles for article (PubMed ID: 27063355)
1. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
MacRitchie N; Volpert G; Al Washih M; Watson DG; Futerman AH; Kennedy S; Pyne S; Pyne NJ
Cell Signal; 2016 Aug; 28(8):946-55. PubMed ID: 27063355
[TBL] [Abstract][Full Text] [Related]
2. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
3. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
6. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
[TBL] [Abstract][Full Text] [Related]
7. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
8. DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
Ferguson BS; Wennersten SA; Demos-Davies KM; Rubino M; Robinson EL; Cavasin MA; Stratton MS; Kidger AM; Hu T; Keyse SM; McKnight RA; Lane RH; Nozik ES; Weiser-Evans MCM; McKinsey TA
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H382-H389. PubMed ID: 34142888
[TBL] [Abstract][Full Text] [Related]
9. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
10. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1.
Józefczuk E; Nosalski R; Saju B; Crespo E; Szczepaniak P; Guzik TJ; Siedlinski M
Hypertension; 2020 Feb; 75(2):383-392. PubMed ID: 31838904
[TBL] [Abstract][Full Text] [Related]
13. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of BODIPY-PF-543.
Shrestha J; Hwang GT; Lee T; Kim SW; Oh YS; Kwon Y; Hong SW; Kim S; Seop Moon H; Baek DJ; Park EY
Molecules; 2019 Dec; 24(23):. PubMed ID: 31810327
[TBL] [Abstract][Full Text] [Related]
15. Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity.
Kim SB; Lee T; Moon HS; Ki SH; Oh YS; Lee JY; Kim SB; Park JE; Kwon Y; Kim S; Baek DJ; Park EY
Molecules; 2020 May; 25(11):. PubMed ID: 32471162
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of selective inhibitors of sphingosine kinase 1.
Baek DJ; MacRitchie N; Pyne NJ; Pyne S; Bittman R
Chem Commun (Camb); 2013 Mar; 49(21):2136-8. PubMed ID: 23388656
[TBL] [Abstract][Full Text] [Related]
17. PKG-1α leucine zipper domain defect increases pulmonary vascular tone: implications in hypoxic pulmonary hypertension.
Ramchandran R; Raghavan A; Geenen D; Sun M; Bach L; Yang Q; Raj JU
Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(7):L537-44. PubMed ID: 25128522
[TBL] [Abstract][Full Text] [Related]
18. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.
Preston IR; Sagliani KD; Warburton RR; Hill NS; Fanburg BL; Jaffe IZ
Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L678-88. PubMed ID: 23457185
[TBL] [Abstract][Full Text] [Related]
20. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
